JPRN-jRCTs051190006
Recruiting
Phase 2
Prospective Evaluation of the Molecular Effects of Itraconazole as an anti-cancer agent: A Window of Opportunity Study - Window trial
Tsubamoto Hiroshi0 sites200 target enrollmentApril 16, 2019
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Tsubamoto Hiroshi
- Enrollment
- 200
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients who have window period before standard treatment
- •And who have no standard treatment
Exclusion Criteria
- •Patients who have drugs which interferes CYP3A
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Prospective Evaluation of the Molecular Effects of Itraconazoleas an anti-cancer agent: A Window of Opportunity Studysolid tumorsJPRN-UMIN000018388Hyogo College of Medicine20
Recruiting
Phase 4
HeberproGen StudyDiabetic foot ulcers.RPCEC00000117Center for Genetic Engineering and Biotechnology (CIGB).156
Not yet recruiting
Phase 2
A clinical trial to study the effects photodynamic therapy in patients with gum diseases.CTRI/2024/06/068905Shweta S Patil
Active, not recruiting
Phase 2
Personalized cancer therapy for CancerCTRI/2018/02/011808Datar Cancer Genetics Limited209
Recruiting
Phase 2
Study of changes in cancer tissue induced by treatment with bevacizumab in metastatic breast cancermetastatic breast cancerCancer - BreastACTRN12609000904279Georgios Kesisis40